CardioReGenix project | June 2023 Meeting

June 21, 2023

The EU-funded CardioReGenix project focuses on technological innovations for the treatment of heart failure and myocardial ischemia. The goal is to overcome obstacles in cardiovascular disease (CVD) gene therapy, capitalising on robust preliminary data and multi-disciplinary consortium know-how in vector development, preclinical and clinical cardiology, business development and clinical translation.

According to WHO estimates, 17.7 million people die each year from CVD, which constitutes more than 30 % of all deaths worldwide. Recent advances in biomedical research improved our understanding of the molecular and cellular mechanisms of the disease and introduced efficient and safer gene therapy vectors for the development of next-generation advanced therapy medicinal products (ATMPs) for CVD.

At ASPHALION we are in charge of the #Regulatory pathway, including scientific consultations with Regulatory Agencies, and the development of the necessary #dossiers which will be used to secure #clinicaltrial authorisation following the #CardioReGenix project and our expert Laura Mendieta attended the meeting to update on the latest regulatory developments.

For further information, you can contact us at:

Search News & Events

  • Filter by category


Related news and events

RBDCOV | Project extension

The European Commission has granted a fifteen-month extension to the EU-funded RBDCOV project, extending the journey to August 31, 2025. This extra time is crucial

VIDEO | FORCE REPAIR animated video

Take a look at this animated video about the FORCE Repair project! Asphalion is in charge of the Regulatory work package of this EU- funded

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting